Literature DB >> 1644919

Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.

L C Wood1, S M Jackson, P M Elias, C Grunfeld, K R Feingold.   

Abstract

The disruption of the cutaneous permeability barrier results in metabolic events that ultimately restore barrier function. These include increased epidermal sterol, fatty acid, and sphingolipid synthesis, as well as increased epidermal DNA synthesis. Because tumor necrosis factor (TNF) and other cytokines are known products of keratinocytes and have been shown to modulate lipid and DNA synthesis in other systems, their levels were examined in two acute models and one chronic model of barrier perturbation in hairless mice. Acute barrier disruption with acetone results in a 72% increase in epidermal TNF 2.5 h after treatment, as determined by Western blotting. Furthermore, epidermal TNF mRNA was elevated ninefold over controls 2.5 h after acetone treatment. This elevation in TNF mRNA was maximal at 1 h after acetone, and decreased to control levels by 8 h. After tape stripping, a second acute model of barrier disruption that avoids application of potentially toxic chemicals, TNF mRNA was elevated fivefold over controls at 2.5 h. Moreover, the mRNA levels for epidermal IL-1 alpha, IL-1 beta, and granulocyte macrophage-colony-stimulating factor (GM-CSF) also were elevated several-fold over controls, after either acetone treatment or tape stripping, but their kinetics differed. GM-CSF mRNA reached a maximal level at 1 h after acetone, while IL-1 alpha and IL-1 beta were maximal at 4 h after treatment. In contrast, mRNAs encoding IL-6 and IFN gamma were not detected either in control murine epidermis or in samples obtained at various times after tape stripping or acetone treatment. The relationship of the cytokine response to barrier function is further strengthened by results obtained in essential fatty acid deficient mice. In this chronic model of barrier perturbation mRNA levels for epidermal TNF, IL-1 alpha, IL-1 beta, and GM-CSF were each elevated several-fold over controls. These results suggest that epidermal cytokine production is increased after barrier disruption and may play a role in restoring the cutaneous permeability barrier.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644919      PMCID: PMC443124          DOI: 10.1172/JCI115884

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Lamellar body secretory response to barrier disruption.

Authors:  G K Menon; K R Feingold; P M Elias
Journal:  J Invest Dermatol       Date:  1992-03       Impact factor: 8.551

Review 2.  Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations.

Authors:  T S Kupper
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Cholesterol synthesis is required for cutaneous barrier function in mice.

Authors:  K R Feingold; M Q Man; G K Menon; S S Cho; B E Brown; P M Elias
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  The effects of an abrasive agent on normal skin and on photoaged skin in comparison with topical tretinoin.

Authors:  R Marks; S Hill; S P Barton
Journal:  Br J Dermatol       Date:  1990-10       Impact factor: 9.302

6.  Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-alpha) in allergic contact dermatitis (rhus dermatitis).

Authors:  C E Griffiths; J N Barker; S Kunkel; B J Nickoloff
Journal:  Br J Dermatol       Date:  1991-06       Impact factor: 9.302

7.  Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin 6.

Authors:  C Grunfeld; S Adi; M Soued; A Moser; W Fiers; K R Feingold
Journal:  Cancer Res       Date:  1990-07-15       Impact factor: 12.701

Review 8.  Structural and lipid biochemical correlates of the epidermal permeability barrier.

Authors:  P M Elias; G K Menon
Journal:  Adv Lipid Res       Date:  1991

9.  Regulation of epidermal sphingolipid synthesis by permeability barrier function.

Authors:  W M Holleran; K R Feingold; M Q Man; W N Gao; J M Lee; P M Elias
Journal:  J Lipid Res       Date:  1991-07       Impact factor: 5.922

10.  Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.

Authors:  W M Holleran; M Q Man; W N Gao; G K Menon; P M Elias; K R Feingold
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

View more
  93 in total

1.  Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis.

Authors:  J B Travers; Q A Hamid; D A Norris; C Kuhn; R C Giorno; P M Schlievert; E R Farmer; D Y Leung
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  The intraepithelial T cell response to NKG2D-ligands links lymphoid stress surveillance to atopy.

Authors:  Jessica Strid; Olga Sobolev; Biljana Zafirova; Bojan Polic; Adrian Hayday
Journal:  Science       Date:  2011-12-02       Impact factor: 47.728

Review 3.  Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.

Authors:  Akiharu Kubo; Keisuke Nagao; Masayuki Amagai
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

Review 4.  Could This Be IT? Epicutaneous, Sublingual, and Subcutaneous Immunotherapy for the Treatment of Food Allergies.

Authors:  Mary Grace Baker; Julie Wang
Journal:  Curr Allergy Asthma Rep       Date:  2019-11-25       Impact factor: 4.806

5.  Changes in keratinocyte differentiation following mild irritation by sodium dodecyl sulphate.

Authors:  M Le; J Schalkwijk; G Siegenthaler; P C van de Kerkhof; J H Veerkamp; P G van der Valk
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

6.  Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing.

Authors:  Chrystelle Bonnart; Céline Deraison; Matthieu Lacroix; Yoshikazu Uchida; Céline Besson; Aurélie Robin; Anaïs Briot; Marie Gonthier; Laurence Lamant; Pierre Dubus; Bernard Monsarrat; Alain Hovnanian
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

7.  Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis.

Authors:  Yutaka Hatano; Mao-Qiang Man; Yoshikazu Uchida; Debra Crumrine; Tiffany C Scharschmidt; Esther G Kim; Theodora M Mauro; Kenneth R Feingold; Peter M Elias; Walter M Holleran
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

Review 8.  New routes for allergen immunotherapy.

Authors:  Pål Johansen; Seraina von Moos; Deepa Mohanan; Thomas M Kündig; Gabriela Senti
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

9.  Keratin 16 regulates innate immunity in response to epidermal barrier breach.

Authors:  Juliane C Lessard; Sylvia Piña-Paz; Jeremy D Rotty; Robyn P Hickerson; Roger L Kaspar; Allan Balmain; Pierre A Coulombe
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

10.  Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements.

Authors:  W M Holleran; W N Gao; K R Feingold; P M Elias
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.